This week’s papers tell a consistent story: mRNA cancer vaccines are moving from broad promise to more practical questions about delivery, personalization, combinations, and who might actually benefit first. 499 papers, 2022–2026. Sponsored by Paperboy.FM Presents.
This week’s papers tell a consistent story: mRNA cancer vaccines are moving from broad promise to more practical questions about delivery, personalization, combinations, and who might actually benefit first.
Surveying 499 papers from 2022 to 2026.
This episode is sponsored by Paperboy.FM Presents.
Key themes: mRNA vaccines, cancer immunotherapy, immunotherapy, cancer treatment, mRNA vaccine, immune response
Most relevant papers:
Want a rapid literature-review podcast on your own topic — with an interactive dashboard, a researcher map, and the contacts behind the work? Create one at paperboy.fm/custom-review.
Generated by Paperboy.FM.
A weekly topical lit-review, plus occasional lit-reviews from community partners.